Comparison of SSFP and IR GRE techniques for measurement of total myocardial mass-influence of applied contrast dosage and implication for relative infarct size assessment

Journal of Cardiovascular Magnetic Resonance

Volumn 9, Issue 3, 2007, Pages 607-614

  Grothues, F ^a   Boenigk, H ^a   Ghanem, A ^a   Schwerdtfeger, A ^a   Bartels, D ^a   Alpers, S ^a   Tempelmann, C ^a   Klein, H U ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cardiovascular Magnetic Resonance; Gadoversetamide; Infarct Size; Late Gadolinium Enhancement; Myocardial Mass

Indexed keywords

CONTRAST MEDIUM; GADOVERSETAMIDE;

ARTICLE; BODY WEIGHT; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; MALE; MULTICENTER STUDY; PERCEPTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STEADY STATE;

CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES;

EID: 33947136313     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1080/10976640600897328     Document Type: Article

References (38)

1. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
2. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-23.
3. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985-91.
4. Pennell DJ, Sechtem UP, Higgins CB, Manning, WJ, Pohost GM, Rademakers FE, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940-65.
5. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wavemyocardial infarction. Lancet 2001;357:21-8.
6. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
7. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-9.
8. Ramani K, Judd RM, Holly TA, Parrish TB, Rigolin VH, Parker MA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998;98:2687-94.
9. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
10. Kitagawa K, Sakuma H, Hirano T, Okamoto S, Makino K, Takeda K. Acute myocardial infarction: myocardial viability assessment in patients early thereafter: comparison of contrast-enhanced MR imaging with resting (201)Tl SPECT. Radiology 2003;226:138-44.
11. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.
12. Kuhl HP, Beek AM, van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341-8.
13. Kaushal R, Fieno D, Radin M, Shaoulian E, Narula J, Goldberger J, et al. Infarct size is an independent predictor of mortality in patients with coronary artery disease [abstract]. J Cardiovasc Magn Reson 2005;7:39A-40A.
14. Caputo GR, Suzuki J, Kondo C, Cho H, Quaife RA, Higgins CB, et al. Determination of left ventricular volume and mass with use of biphasic spin-echo MR imaging: comparison with cine MR. Radiology 1990;177:773-7.
15. Florentine MS, Grosskreutz CL, Chang W, Hartnett JA, Dunn VD, Erhardt JC, et al. Measurement of left ventricular mass in vivo using gated nuclear magnetic resonance imaging. J Am Coll Cardiol 1986;8:107-12.
16. Forbat SM, Karwatowski SP, Gatehouse PD, Firmin DN, Longmore DB, Underwood SR. Rapid measurement of left ventricular mass by spin echo magnetic resonance imaging [technical note]. Br J Radiol 1994;67:86-90.
17. Matheijssen NA, Baur LH, Reiber JH, van der Velde EA, van Dijkman PR, van der Geest RJ, et al. Assessment of left ventricular volume and mass by cine magnetic resonance imaging in patients with anterior myocardial infarction: intra-observer and inter-observer variability on contour detection. Int J Card Imaging 1996;12:11-9.
18. Sakuma H, Fujita N, Foo TK, Caputo GR, Nelson SJ, Hartiala J, et al. Evaluation of left ventricular volume and mass with breath-hold cine MR imaging. Radiology 1993;188:377-80.
19. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of Cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29-34.
20. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000;2:271-8.
21. Fuchs F, Laub G, Othomo K. TrueFISP - technical considerations and cardiovascular applications. Eur J Radiol 2003;46:28-32.
22. Moon JC, Lorenz CH, Francis JM, Smith GC, Pennell DJ. Breathhold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology. 2002;223:789-97.
23. Plein S, Bloomer TN, Ridgway JP, Jones TR, Bainbridge GJ, Sivananthan MU. Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging. 2001;14:230-6.
24. Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF. MR evaluation of ventricular function: true fast imaging with steady-state free precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology. 2001;219:264-9
25. Kim RJ, Albert TSE, Wible JH Jr, Elliott MD, Allen JC Jr, Lee JC, Napoli A, Judd RM. Efficacy of gadoversetamide-enhanced MRI for the diagnosis and assessment of myocardial infarction: an international, multicenter, double-masked, randomized, phase 2 trial [abstract]. J Am Coll Cardiol 2005;45:287A-8A.
26. Kaufman L, Kramer DM, Crooks LE, Ortendahl DA. Measuring signal-to-noise ratios in MR imaging. Radiology 1989;173:265-7.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
28. McDonald KM, Parrish T, Wennberg P, Stillman AE, Francis GS, Cohn JN, et al. Rapid, accurate and simultaneous noninvasive assessment of right and left ventricular mass with nuclear magnetic resonance imaging using the snapshot gradient method. J AmColl Cardiol 1992;19:1601-7.
29. Shapiro EP, Rogers WJ, Beyar R, Soulen RL, Zerhouni EA, Lima JA, et al. Determination of left ventricular mass by magnetic resonance imaging in hearts deformed by acute infarction. Circulation 1989;79:706-11.
30. Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005;112:1462-9.
31. Thiele H, Engelmann L, Elsner K, Kappl MJ, Storch WH, Rahimi K, et al. Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 2005;26:1956-63.
32. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8.
33. van Dockum WG, ten Cate FJ, ten Berg JM, Beek AM, Twisk JW, Vos J, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 2004;43:27-34.
34. Slomka PJ, Fieno D, Thomson L, Friedman JD, Hayes SW, Germano G, et al. Automatic detection and size quantification of infarcts by myocardial perfusion SPECT: clinical validation by delayed-enhancement MRI. J Nucl Med 2005;46:728-35.
35. Haase J, Bayar R, Hackenbroch M, Storger H, Hofmann M, Schwarz CE, et al. Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol 2004;17:367-73.
36. Petersen SE, Mohrs OK, Horstick G, Oberholzer K, Abegunewardene N, Ruetzel K, et al. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 2004;6:541-8.
37. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253-9.
38. Azevedo Filho CF, Hadlich M, Petriz JL, Mendonca LA, Moll Filho JN, Rochitte CE. Quantification of left ventricular infarcted mass on cardiac magnetic resonance imaging: comparison between planimetry and the semiquantitative visual scoring method. Arq Bras Cardiol 2004;83:118-24.